Literature DB >> 32819675

Influence of fellowship educational experience on practice patterns for adrenalectomy: A survey of recent AAES fellowship graduates.

Jessica Fazendin1, Herbert Chen2, Brenessa Lindeman2.   

Abstract

BACKGROUND: Current practice patterns for adrenalectomy among endocrine surgeons is a limited area of study. Here we survey relatively junior endocrine surgeons regarding educational experiences in adrenalectomy and correlate these with current practice.
METHODS: An electronic survey was sent to recent AAES-accredited fellowships graduates (2014-2019), querying adrenalectomy volume and approaches during fellowship and current practice patterns.
RESULTS: Most graduates (63.2%) performed >20 adrenalectomies in fellowship. Exposure was greatest to open (94.1%) and laparoscopic transabdominal (92.6%) adrenalectomy, followed by retroperitoneoscopic (86.7%). The majority (73.5%) of respondents stated their current practice patterns are the same as their exposure during training. Preoperative diagnosis, side of lesion, and patient comorbidities were all ranked as significant predictors affecting choice of approach (p < 0.001).
CONCLUSION: The large majority of AAES fellowship graduates receive high-volume adrenalectomy experience in several approaches. The technique to which a trainee was exposed to most frequently was the greatest predictor for preferential approach in current practice.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AAES fellowship; Adrenalectomy; Education; Endocrine; Retroperitoneoscopic; Training

Mesh:

Year:  2020        PMID: 32819675     DOI: 10.1016/j.amjsurg.2020.07.027

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  1 in total

1.  Patient Satisfaction is Equivalent for Inpatient and Outpatient Minimally-Invasive Adrenalectomy.

Authors:  Richard Augusto Pigg; Jessica M Fazendin; John R Porterfield; Herbert Chen; Brenessa Lindeman
Journal:  J Surg Res       Date:  2021-09-30       Impact factor: 2.192

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.